Efficacy of a third SARS-Co V-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR
T cell, and BiTE recipients. Cancer Cell 40(4):340-342. PMCID: PMC8864440
Date
04/11/2022
Author List
Abid MB, Rubin M, Ledeboer N, Szabo A, Longo W, Mohan M, Shah NN, Fenske TS, Abedin S, Runaas L, D'Souza A, Chhabra S, Dhakal B, Hamadani M.
Author
Walter L. Longo MD Professor in the Medicine department at Medical College of Wisconsin